Perelman School of Medicine: Updated Data Show Promise of Targeted Therapy in Castleman Disease
May 09, 2020
May 09, 2020
UNIVERSITY CITY, Pennsylvania, May 9 [TNSmedicalresearch] -- The University of Pennsylvania's Perelman School of Medicine issued the following news release:
Six years ago, David C. Fajgenbaum, MD, MBA, MSc, both a Penn Medicine researcher and patient, tried an experimental treatment based on his laboratory research findings in the hopes of saving his own life. He has been in remission ever since. Now his further research is shedding new light on why it worked, paving the way for fur . . .
Six years ago, David C. Fajgenbaum, MD, MBA, MSc, both a Penn Medicine researcher and patient, tried an experimental treatment based on his laboratory research findings in the hopes of saving his own life. He has been in remission ever since. Now his further research is shedding new light on why it worked, paving the way for fur . . .